Free with registration - PR Newswire - AccessMyLibrary.com - Sep 14, 2006 Additional data presented at the meeting showed that ACTOS improved components of diabetic dyslipidemia, a condition commonly found in people with type 2 ...
Medical News Today - Medical News Today (press release) - Sep 17, 2006 Additional data presented at the meeting showed that ACTOS improved components of diabetic dyslipidemia, a condition commonly found in people with type 2 ...
Diabetes In Control - Sep 19, 2006 Additional data presented at the meeting showed that Actos improved components of diabetic dyslipidemia, a condition commonly found in people with type 2 ...
Free with registration - PR Newswire - AccessMyLibrary.com - Apr 3, 2006 A small number of people who have taken metformin, a component of ACTOplus met(TM) ... Neither ACTOS nor ACTOplus met should be used in type 1 diabetes. ...
Medical News Today - Medical News Today (press release) - Apr 6, 2006 A small number of people who have taken metformin, a component of ACTOplus metTM ... Neither ACTOS nor ACTOplus met should be used in type 1 diabetes. ...
Diabetes In Control - Aug 8, 2006 On July 28, the FDA approved pioglitazone HCl (Actos) plus glimepiride ... with type 2 diabetes who are already receiving a combination of the 2 components ...
Free with registration - PR Newswire - AccessMyLibrary.com - Jul 31, 2006 Duetact combines ACTOS(R)(pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet. ACTOS ...
Free with registration - PR Newswire - AccessMyLibrary.com - Nov 7, 2006 Duetact combines ACTOS(R) (pioglitazone HCl) and glimepiride, two widely used diabetes medications with complementary actions, in a single tablet. ACTOS ...
Pay-Per-View - PR Newswire - HighBeam Research - Apr 3, 2006 A small number of people who have taken metformin, a component of ACTOplus met(TM) ... Neither ACTOS nor ACTOplus met should be used in type 1 diabetes. ...
DG News - Nov 16, 2006 In a 6-month treatment period, the necrotic-core components of plaques decreased when patients were taking the anti-diabetes drug pioglitazone (Actos), ...
